Pebblebrook Hotel Trust — Form 8-K
Filed July 29, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 58/100
What the filing says
Pebblebrook reported Q2 2026 Same-Property Hotel EBITDA of $123.3M (+7.1% YoY), exceeding guidance by $6.6M. Same-Property RevPAR grew +6.5% (ADR +4.7%, occupancy +1.7%). The company raised full-year 2026 Adjusted FFO guidance to $1.69–$1.76/share (midpoint +$0.08) and Adjusted EBITDAre to $345–$353M (midpoint +$8.5M). On May 27, 2026, Pebblebrook sold the 115-room Chamberlain West Hollywood Hotel for $43.5M, accepting $26.1M of preferred shares at a 23% discount to retire them. Net debt/TTM EBITDA improved to 5.3x; $270.4M cash available; $350M December 2026 convertible notes fully funded.
Why this rating
Strong operational beat and raised guidance are positive; modest M&A activity ($43.5M sale ≈3.6% of market cap) and improved leverage are favorable. Not transformational—EBITDA growth ~9% YoY is solid but asset sales reduce portfolio and offset earnings impact.
See more from July 29, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.